SynthesisCancer medicine2021

Systematic review of phase-I/II trials enrolling refractory and recurrent Ewing sarcoma: Actual knowledge and future directions to optimize the research.

Arthur Felix et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.